过高糖化作为阿尔茨海默氏症疾病的中心代谢驱动因素
bioRxiv : the preprint server for biology
|July 14, 2025
概括
阿尔茨海默病与异常的糖分子积累 (超糖化) 有关. 调节这个过程,例如通过避免葡萄糖胺,可能为阿尔茨海默病 (AD) 和相关痴呆症 (ADRD) 提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 格莱科米克斯 (Glycomics) 是一个有趣的药物.
背景情况:
- 阿尔茨海默病 (AD) 涉及代谢干扰,但它们在疾病分子起源中的作用尚不清楚.
- 过高糖化,过多的糖分子,被确定为AD的一个关键特征.
研究的目的:
- 为了研究过高糖化在阿尔茨海默病发病中的作用.
- 探索甘氨酸代谢作为阿尔茨海默病的潜在治疗点.
主要方法:
- 在小鼠模型和人类样本中使用了空间代谢学,脂组学和糖组学.
- 先进的空间同位素追踪研究了N链 glycan 动态.
- 进行了基因和饮食干预,包括补充葡萄糖胺.
主要成果:
- 阿尔茨海默病的特点是高糖化表型和增强的甘氨酸生物合成.
- 在AD小鼠中,基因减少甘氨酸合成改善了认知功能.
- 葡萄糖胺补充剂恶化了类似阿尔茨海默病的症状,并且与人类队伍的死亡率增加和疾病进展有关.
结论:
- 过高糖化是阿尔茨海默病的病理驱动因素.
- 葡萄糖代谢代表了阿尔茨海默氏症和阿尔茨海默氏症相关痴呆症 (ADRD) 的有前途的治疗标.
相关概念视频
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Oligosaccharide Assembly
3.0K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.0K
Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
Overview of Carbohydrate Metabolism
1.9K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.9K
Protein Glycosylation
7.3K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
7.3K
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263


